• Profile
Close

Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer

JAMA Nov 03, 2021

Chavez-MacGregor M, Lei X, Zhao H, et al. - Researchers performed comparisons between patients with COVID-19 with or without cancer with respect to the rates of death, mechanical ventilation, intensive care unit stay, and hospitalization.

  • Using the Optum de-identified COVID-19 electronic health record data set, a cohort study of more than 500,000 US adults who were diagnosed with COVID-19 was performed.

  • Outcomes revealed an increased risk of death, intensive care unit admission, and hospitalization among patients with cancer who received anticancer treatment within 3 months before COVID-19 diagnosis.

  • Similar or better outcomes were recorded for patients without recent cancer treatment when compared with those without cancer.

  • Overall findings have risk stratification as well as resource use implications for patients, clinicians, and health systems.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay